Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.

New Jersey's Senate Resolution 22 (SR 22) is a non-binding resolution urging the U.S. Supreme Court to resolve conflicting federal court rulings about mifepristone, a drug used for medical abortions and other reproductive health treatments. It specifically asks the Court to prioritize public health, respect medical expertise, and ensure continued access to mifepristone - currently under legal dispute following the FDA's 2000 approval and a 2023 Texas court ruling attempting to ban it. The resolution directly affects individuals relying on mifepristone for reproductive care, particularly in states with restrictive abortion laws. It does not change laws but calls for the Supreme Court to clarify the drug's legal status to prevent widespread access loss.